Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1992 Dec;21(12):1468-71.
doi: 10.1016/s0196-0644(05)80063-0.

Prevention of hyperbaric-associated middle ear barotrauma

Affiliations
Clinical Trial

Prevention of hyperbaric-associated middle ear barotrauma

S Carlson et al. Ann Emerg Med. 1992 Dec.

Abstract

Study objective: To determine the efficacy of topical nasal decongestant in the prevention of middle ear barotrauma in patients undergoing hyperbaric oxygen therapy.

Design: Prospective, parallel, double-blind, randomized trial.

Setting: University-affiliated community hospital emergency department with hyperbaric oxygen facilities.

Participants: Sixty patients undergoing hyperbaric oxygen therapy; 30 subjects in each treatment arm.

Interventions: After randomization, consenting patients were given two sprays of oxymetazoline hydrochloride or sterile water, 15 minutes before hyperbaric oxygen therapy. Collected data included patient demographics, ear examinations before and after hyperbaric oxygen treatment, and subjective ear complaints. The otoscopic appearance of the tympanic membrane was graded according to the amount of hemorrhage in the eardrum, with Teed scores ranging from 0 (symptoms only) to 5 (gross hemorrhage and rupture).

Results: The treatment groups were similar with regard to age, sex, and medical history. Ear discomfort during hyperbaric oxygen therapy was present in 63% (19 of 30) of those receiving oxymetazoline versus 67% (20 of 30) of the control group (P = .99). Likewise, both groups had similar Teed scores after hyperbaric oxygen therapy (P = .88). No adverse effects were noted.

Conclusion: The results of this pilot study suggest that topical decongestants may not be effective in preventing middle ear barotrauma during hyperbaric oxygen therapy.

PubMed Disclaimer

Publication types

LinkOut - more resources